For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Intracranial hypertension (IH) is a condition in which pressure builds in the fluid around the brain. Here’s what you should know about IH, the symptoms, and what treatments may help. Your brain ...

Brain swelling, or cerebral edema, is a medical emergency. Learn about the evidence-based treatments doctors use to reduce ...

Idiopathic intracranial hypertension is caused by a buildup of cerebrospinal fluid (CSF) in the skull. Intracranial buildup of CSF can cause symptoms like pressure, pain, and vision changes over time.

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

"That would pose intracranial pressure control as a brand-new, pharmacologically targetable pathway." Mild gastrointestinal side effects (mainly nausea and constipation) occurred in 38% of ...

GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...

A technology developed by the Brazilian company brain4care has been shown to be able to measure absolute values of ...

KOLOA, Hawaii — Intracranial pressure may be just as critical of a factor in the progression of glaucoma as IOP, according to a speaker here at Hawaiian Eye 2025.